BioNTech RNA Pharmaceuticals GmbH;TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
发明人:
SAHIN, UGUR,HAAS, HEINRICH,KREITER, SEBASTIAN,DIKEN, MUSTAFA,FRITZ, DANIEL,MENG, MARTIN,KRANZ, LENA MAREEN,REUTER, KERSTIN
申请号：
PL13713356
公开号：
PL2830593T3
申请日:
2013.03.25
申请国别(地区):
PL
年份:
2019
代理人:
摘要：
The present invention is in the field of immunotherapy, in particular tumor immunotherapy. The present invention provides pharmaceutical formulations for delivering RNA to antigen presenting cells such as dendrite cells (DCs) in the spleen after systemic administration. In particular, the formulations described herein enable to induce an immune response after systemic administration of antigen-coding RNA.
